WO2016025934A1 - Stérilisateur à l'ozone portable autonome pour petit équipement médical - Google Patents
Stérilisateur à l'ozone portable autonome pour petit équipement médical Download PDFInfo
- Publication number
- WO2016025934A1 WO2016025934A1 PCT/US2015/045434 US2015045434W WO2016025934A1 WO 2016025934 A1 WO2016025934 A1 WO 2016025934A1 US 2015045434 W US2015045434 W US 2015045434W WO 2016025934 A1 WO2016025934 A1 WO 2016025934A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ozone
- sterilization
- air
- assembly
- inner chamber
- Prior art date
Links
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 title claims abstract description 291
- 230000001954 sterilising effect Effects 0.000 claims abstract description 135
- 238000000034 method Methods 0.000 claims abstract description 28
- 238000004659 sterilization and disinfection Methods 0.000 claims description 135
- 239000003570 air Substances 0.000 claims description 60
- 230000006378 damage Effects 0.000 claims description 34
- 239000012080 ambient air Substances 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims 3
- 230000002906 microbiologic effect Effects 0.000 claims 3
- 230000005611 electricity Effects 0.000 abstract description 2
- 239000000446 fuel Substances 0.000 abstract description 2
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 74
- 230000001580 bacterial effect Effects 0.000 description 29
- 238000003556 assay Methods 0.000 description 24
- 238000002835 absorbance Methods 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 239000001963 growth medium Substances 0.000 description 19
- 230000002147 killing effect Effects 0.000 description 19
- 239000000126 substance Substances 0.000 description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 235000014469 Bacillus subtilis Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000588626 Acinetobacter baumannii Species 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 241000588747 Klebsiella pneumoniae Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 239000006916 nutrient agar Substances 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 229910001220 stainless steel Inorganic materials 0.000 description 6
- 239000010935 stainless steel Substances 0.000 description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- -1 electrical power Substances 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000013207 serial dilution Methods 0.000 description 5
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 4
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- 239000001974 tryptic soy broth Substances 0.000 description 4
- 108010050327 trypticase-soy broth Proteins 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 239000004155 Chlorine dioxide Substances 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 235000019398 chlorine dioxide Nutrition 0.000 description 3
- 230000001332 colony forming effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 241001581112 Alchemilla haumanii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000272194 Ciconiiformes Species 0.000 description 2
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 101000737813 Homo sapiens Cyclin-dependent kinase 2-associated protein 1 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 101000760620 Homo sapiens Cell adhesion molecule 1 Proteins 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 108090000237 interleukin-24 Proteins 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- GELKBWJHTRAYNV-UHFFFAOYSA-K lithium iron phosphate Chemical compound [Li+].[Fe+2].[O-]P([O-])([O-])=O GELKBWJHTRAYNV-UHFFFAOYSA-K 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 239000012569 microbial contaminant Substances 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/202—Ozone
Definitions
- the present invention relates to a lightweight, portable, self-contained sterilization apparatus whose operation does not require external power sources.
- the invention more specifically, relates to an apparatus that uses self-generated ozone for sterilization and disinfection of small medical, dental and surgical instruments.
- the apparatus is designed to function in field conditions where water, electrical power, and/or fuel sources may be absent, unavailable, or of limited availability.
- cliloride dioxide gas requires sodium hypochlorite and chlorine gas, if using the dry process; and sodium hypochlorite and hydrochloric acid, if using the wet process (Lowe, Gibbs, Iwen, Smith, Sc Hewlett, 2013; Rastogi et ah, 2010). Aerosolized hydrogen peroxide relies on a source of 5% hydrogen peroxide to generate the aerosol (Andersen et al., 2006). while carbon dioxide gas requires a tank of carbon dioxide (Zhang et al., 2006).
- Patent No. 8.133,450 to Doona et al. describes a portable chemical sterilizer adapted to controilably generate sterilization conditions inside the apparatus using a chemical combination.
- this chemical based sterilizer is light-weight and self-contained, the chemical combination used for sterilization needs to be frequently replaced, which still pose logistic problems relating to the transportation and storage of these chemicals. Furthermore, after sterilization, gaseous chemical reaction products or excessive heat is released directly into the environment housing the sterilizer, which renders this sterilizer unsuitable for use in a small enclosed area.
- the ozone technology has many advantages over other sterilization methods, it eliminates pre-conditioning, does not require post sterilization dwelling, and allows heat-sensitive devices to be sterilized without compromising materials compatibility, product quality or integrity, while allowing for a rapid turnaround room-temperature sterilization method for medical and dental devices.
- these systems are often bulky and non-portable requiring external ozone or electrical sources.
- Handheld ozone sterilizer has been developed, but mostly for sterilization of food and articles of daily use, such as those described in Chinese Patent No. CN 2142020 and Chinese Patent No, CN 202945057. However, these devices are not powerful enough to provide sterilization required for medical setting.
- FIG L Schematic of the ozone sterilization Chamber System
- FIG. Normalized turbidity at O.D. 600nm of Acinetobacter baumannii strain BAA 1605. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%. or 100%, Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 3. Normalized turbidity at O.D. 600nm of Acineiobader baumannii strain ATCC 17961. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times, Post-treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 4. Normalized turbidity at O.D. 600nm of Acineiobader baumannii strain ATCC 19606. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and Incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates. [005] FIG 5.
- FIG 6. Normalized turbidity at O.D. 600nm of Acinetohacier baumannii strain WRAMC #13. The ozone treated plates of bacteria were exposed to ozone for 5. 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600rmi for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 7. Normalized turbidity at O.D. 600nm of Bacillus subdlis strain JH 642. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 6G0mrs for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 8. Normalized turbidity at O.D. 600nm of Escherichia colt strain JM 109. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post- treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures, Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 9. Normalized turbidity at O.D. 600nm of Klebsiella pneumonia strain BAMC 07-18. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment culture media was added and incubated overnight at 37°C, Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 10. Normalized turbidity at O.D. 600nm of Klebsiella pneumonia strain xen ⁇ 39. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%o, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 11. Normalized turbidity at O.D. 600nm of Klebsiella pneumonia strain I ⁇ -525. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30. or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%, Control plates of bacteria were left untreated for equivalent times. Post- treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates,
- FIG 12 Normalized turbidity at Q.D, 600nm of Pseudomonas aeruginosa strain Xcn-41.
- the ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%.
- Control plates of bacteria were left untreated for equivalent limes, Post-treatment, culture media was added and incubated overnight at 37°C Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures.
- Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 13. Normalized turbidity at Q.D. 600nm of Pseudomonas aeruginosa strain BAMC 07-4 The ozone treated plates of bacteria were exposed to ozone for 5, 15. 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times, Post-treatment, culture media was added and incubated overnight at 37°C, Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 14. Normalized turbidity at O.D. 600nm of Pseudomonas aeruginosa strain PAOl .
- the ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%.
- Control plates of bacteria were left untreated for equivalent times, Post-treatment, culture media was added and incubated overnight at 37°C.
- Turbidity was assayed by absorbance at 6G0nm for both controls and ozone treated cultures, Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 15. Normalized turbidity at 01), 600nm of Staphylococcus aureus strain IQ0070.
- the ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%, Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C. Turbidity was assayed by absorbance at 600nrn for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 16. Normalized turbidity at O.D, 600nm of Staphylococcus aureus strain Xen-40. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at. 37°C. Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates,
- FIG 17. Normalized turbidity at O.D. 600nm of Staphylococcus aureus strain ATCC 33591. The ozone treated plates of bacteria were exposed to ozone for 5, 15, 30, or 60 minutes at an ozone output of 25%. 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C, Turbidity was assayed by absorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted, Error bars indicate standard deviation of three technical replicates.
- FIG 18. Normalized turbidity at O.D. 600nm of Staphylococcus aureus strain TCH- 1516. The ozone treated plates of bacteria were exposed to ozone for 5, 15. 30, or 60 minutes at an ozone output of 25%, 50%, 75%, or 100%. Control plates of bacteria were left untreated for equivalent times. Post-treatment, culture media was added and incubated overnight at 37°C, Turbidity was assayed by ahsorbance at 600nm for both controls and ozone treated cultures. Ozone treated samples were normalized versus control samples, and averages plotted. Error bars indicate standard deviation of three technical replicates.
- FIG 19. Ozone Sterilization Phase.
- the diagrams show the primary components of the ozone sterilizer system during Sterilization, Portions shown in grey are active or open, while portions shown in black are inactive or closed. Grey and black dashes indicated portions that are cycled on and off.
- FIG 20, Ozone Destruction Phase The diagrams show the primary components of the ozone sterilizer system during destruction. Portions shown in grey are active or open, while portions shown in black are inactive or closed.
- FIG 21 User interface during primary state of operation.
- FIG 22 Sterilizer wiring diagram.
- a simplified wiring diagram shows power distribution to sterilization system components.
- a rectifier converts 120 VAC into 12VDC when the system is powered externally, and a 12 VDC battery is used when the system is powered internally.
- a DC-DC converter provides the voltage required by the ozone sensor, and an inverter provides a high voltage AC signal to the ozone generator 1.
- Microprocessor-controlled relays energize the ozone generator 1. pump 6, and solenoid valves 8,
- FIG 23 Ozone Sterilizer Configurations.
- the diagrams show the primary components of the ozone sterilizer in the two configurations that were tested.
- air enters the system through the air dryer 5 and exists through the sterilization compartment 4.
- air is recirculated through the system, flowing through the active ozone generator 1 during sterilization, During the destruction phase at the end of sterilization, air is redirected through the ozone destruction unit 7 (dashed lines).
- FIG 24 Normalized turbidity of ozone treated bacteria in an open-loop configuration, Bacteria were treated during a 60-minute sterilization cycle. Control plates of bacteria were left untreated for the equivalent time. Post-treatment, sterile media was added and incubated overnight at 37 °C. Turbidity was measured using a spectrometer for both control and treated cultures. Treated samples were normalized to the control samples, and averages plotted. Error bars indicate the standard deviation of ten technical replicates.
- FIG 25 Normalized turbidity of ozone treated bacteria in a closed-loop configuration. Bacteria were treated during a 60 ⁇ minute sterilization cycle. A) E. coii, B) A. baumannii, C) B. subtilis, D), K, pneumoniae, E) P. aeruginosa, F) S. aureus. Control plates of bacteria were left untreated for equivalent times. Post treatment, sterile media was added and incubated overnight at 37 °C. Turbidity was measured using a spectrometer for both control and treated cultures. Ozone treated samples were normalized to the control samples, and averages plotted. Error bars indicate the standard deviation of three experimental and ten technical replicates.
- FIG 26 Normalized turbidity of ozone treated dental instruments in a closed-loop configuration. Bacteria were treated during a 60-minute sterilization cycle. Control dental instruments were left untreated for equivalent times, Post treatment, dental instruments were placed in sterile media and incubated overnight at 37°C. Turbidity was measured using a spectrometer for both control and treated cultures. Ozone treated samples were normalized to the control samples, and averages plotted, *Note: Dental mirrors results not shown. Error bars indicate the standard deviation of four technical replicates DETAILED DESCRIPTION OF THE INVENTION
- This application describes the utilization of a portable medical sterilization system employing ozone technology.
- the technology eliminates pre-conditioning, does not require post sterilization dwelling, and allows heat-sensitive devices to be sterilized without compromising materials compatibility, product quality or integrity.
- This technology allows for a rapid turnaround room-tempeFIGrature sterilization method for medical and dental devices.
- the inventive apparatus is a field deployable sterilization chamber system being developed for utilization at the
- This invention allows ozone generation by a battery-powered sterilization chamber system solely reliant on ambient air, thus removing the current needs for external electrical sources, or additional cargo required as in gaseous or liquid sterilizers,
- An embodiment of the inventive ozone sterilizer comprising ozone sterilizer system contained in a ruggedized and portable case with seven primary mechanical components that are monitored and controlled by a microcontroller,
- the ozone sterilizer assembly comprising: 1) an ozone generator 1, 2) an ozone sensor 2, 3) a humidifier 3 4) a sterilization compartment 4, 5) an air dryer 5, 6) a pneumatic pump 6, 7) an ozone destruction unit 7 (FIGs 19 and 20).
- the pump 6 circulates air through the system, and solenoid valves 8 direct air flow to different portions of the system depending on the status of the sterilization cycle.
- the ozone generator 1 In the Sterilization Phase, the ozone generator 1 is active, and the pump 6 circulates ozonated air into the sterilization compartment 4, while recycling air from the sterilization compartment 4 back to the generator 1 , An ozone sensor 2 monitors the generator output, and when the ozone concentration reaches a target level, the sterilization timer begins.
- the humidifier 3 switches on and off to add moisture to the sterilization compartment 4.
- the ozone generator 1 turns off, and solenoid valves 8 redirect air to the ozone destruction unit 7 to convert any remaining ozone back into oxygen.
- the air dryer 5 is used to remove moisture from incoming air entering the system to ensure proper functions and extend life of the pump 6, ozone generator 1 , and ozone sensor 2.
- Ozone Generator 1 - Ozone is powerful oxidizing agent that is unstable at high concentrations, which quickly decaying into oxygen.
- ozone must be generated by the system (Guzel-Seydim, 2003).
- Ozone can be produced from either pure oxygen, or ambient air. via either UV light or a corona discharge, and has been shown to be effective at killing bacteria, including spores (Kowalski, Brufieth, & Whittam, 1998; Nagayoshi et al, 2004; Young & Setlow, 2004).
- the corona discharge method is employed to generate ozone.
- Corona discharge is a cost-effective, small form-factor method for producing ozone from ambient air, which can result in high ozone output with relatively low energy costs compared to other ozone-generating techniques (Surnmerfelt, 1997).
- the ozone generator 1 produces heat as a byproduct, which reduces the efficiency of the generator I , so heat removal was an important design consideration for the system (Carlins, 1982),
- the corona discharge generator selected for this invention features a tube design with heat sinks nmning the full length of the tube. Cooling fans may also be incorporated into the system to remove excess heat and maximize generator efficiency.
- Ozone Sensor 2- An ultraviolet (UV) system ozone sensor 2 may be used to measure ozone concentration entering the sterilization compartment 4 by weight.
- the sensor 2 compensates for temperature and pressure fluctuation, and uses two detectors, one to measure ozone concentration, and the other to adjust for changes in the UV light intensity, allowing the sensor 2 to operate for extended periods without calibration or maintenance.
- the ozone sensor 2 provides feedback to the system's microcontroller or processor to ensure the sterilization compartment 4 receives the target ozone concentration during the sterilization cycle and to verify that all ozone is removed during the destruction phase.
- the sensor 2 selected for the prototype system contains a microprocessor and can communicate with other devices using the RS232 serial eomrmrnieation protocol.
- Humidifier 3- Previous tests have shown that gaseous ozone in the presence of moisture is more effective at killing bacteria than dry ozonated air. Therefore, a bubble humidifier 3 was added at the inlet of the sterilization compartment 4 to add moisture to the air entering the chamber (Sbarma, 2008), A second input to the sterilization compartment 4 bypasses the humidifier 3, allowing humidity to be controlled by switching the humidifier 3 branch on and off.
- the humidifier 3 compartment is made of polycarbonate and filled with water. A crashed glass stem circulates ozonated ai r into the water, producing small bubbles, allowing moisture to be picked up by the dry, ozonated air.
- Sterilization Compartment 4 A sterilization compartment 4 was designed to hold small medical instruments.
- the prototype sterilization compartment 4 measures 15" x 6" x 6".
- the compartment 4 has a hinged top with an airtight seal to prevent ozone from escaping during the sterilization cycle.
- the compartment 4 is constructed of ozone-compatible polycarbonate siding with a silicone seal. Medical instruments are placed on a stainless steel mesh, resting
- Air Dryer 5 ⁇ Several system components, including the pump 6, ozone generator 1, and ozone sensor 2, require dry air to operate efficiently. Therefore, an air dryer S is placed at the input of the sterilization system to remove any moisture added by the humidifier 3 (Carlins, 1982).
- the air dryer 5 is made of stainless steel, and uses a rechargeable silica desiccant, A moisture indicator placed downstream of the air dryer 5 indicates when the desiccant is saturated.
- Pump 6 A diaphragm pump is selected that features all ozone-compatible wetted materials, including a Teflon-coated aluminum head, and a Teflon diaphragm.
- the pump 6 is driven by a brushless DC motor, which pushes air through the system at a rate of 5 liters per minute, resulting in a full air exchange in the sterilization compartment 4 approximately once every minute.
- the ozone destruction unit 7 may be made of stainless steel and uses a low-temperature oxidation catalyst to eliminate remaining ozone by converting it into oxygen.
- the sterilization system is controlled by a microprocessor or microcontroller, such as iOS Mega microprocessor.
- the microprocessor receives user input, provides status information to the operator, communicates with the ozone sensor 2, controls the ozone generator 1 and pump 6, and actuates solenoid valves 8 that distribute air flow to different portions of the system.
- Any common interfaces for the microprocessor/microcontroller may be used to display information during operation and accepts inputs.
- the interface used for the prototype is a 3.2" LCD touchscreen panel that allows user input via virtual buttons,
- the portable medical sterilization system this invention may operate in either open-loop configuration or closed-loop configuration (FIG 23).
- open-loop configuration ambient air enters the system through an air dryer S and is pumped through the ozone generator 1, humidifier, and into the sterilization compartment 4,
- the air dryer 5 removes moisture from air entering the system, increasing the output of the ozone generator 1 and extending the life of the pump 6, ozone generator 1. aid ozone sensor 2.
- the humidifier 3 adds moisture to the air prior to entering the sterilization compartment 4, which has been shown to facilitate the ozone sterilization process (Sharma, 2008).
- an enclosure such as a fume hood
- average ozone concentrations range between 4.2 and 6.3 g/Nm3. Peak concentrations are generated at the beginning of the cycle and fall slightly to a steady-state value at around 20 minutes. Humidity levels range between 65% and 75%, and the temperature gradually rises during the process, beginning at 29 °C and reaching 33 °C at the end of the cycle.
- the closed-loop configuration expands on the original design and affords a greater level of efficiency arid control over environmental parameters during the sterilization process.
- the process is split into two distinct phases: sterilization and destruction.
- sterilization the ozone generator 1 is active and the pump 6 circulates ambient air through the closed-loop system. Once the sterilization cycle is complete, the system enters a destruct cycle to eliminate remaining ozone.
- the air circulating through the sterilizer is diverted to an ozone destruction unit 7, which contains an oxidation catalyst that converts the remaining ozone into oxygen.
- the recirculating air passes through the destruction unit 7 multiple times to ensure the ozone is removed before the sterilization compartment 4 is opened (Dory, 2014).
- Average ozone concentrations in the closed-loop configuration range between 5.4 and 6.8 g/Nm3, again peaking at the beginning of the cycle. Humidity and temperature level are consistent, with the open-loop configuration, 65-75% and 29 - 33°C, respectively.
- Idle There are five primary states of operation of this inventive sterilizer controlled by inputs from the user via a microcontroller or processor: Idle, Setup, Maintenance, Sterilization, and Destruction (FIG 21 ).
- Idle the device first enters the Idle State, in which the ozone generator 1 is off, the pump 6 is off. the air vent is open, the ozone destruction unit 7 is bypassed, the humidifier 3 Is bypassed, and the ozone sensor 2 is energized.
- the ozone sensor 2 requires a 15-minute warm-up period; therefore, as soon as the ozone sensor 2 is energized, a 15-minute internal timer begins,
- the user can enter the Setup state. T he Setup window allows sterilization cycle parameters to be defined and saved. The user can set the sterilization runtime, destruction runtime, and minimum Häshold ozone concentration for the sterilization cycle. During the sterilization cycle, the sterilization runtime timer begins only once the minimum threshold concentration is reached. From the Setup window, the user can also define the duty cycle of the humidifier 3 and the ozone generator 1, For instance, the ozone generator 1 can be configured to turn off once an upper threshold is reached and turn back on once the ozone concentration fall below a lower threshold, allowing the system to consen'e energy. When the user presses the "Save and Exit" button, the values are stored in the microprocessor's memory, and processor returns to the Idle State,
- the Maintenance state allows the user to actuate different components of the system independently to facilitate troubleshooting and maintenance.
- the ozone generator 1, pump 6, and actuating valves 8 can be independently toggled on and off.
- the valves 8, pump 6, and generator 1 are ail returned to Idle State values.
- the sterilization state begins.
- the processor first checks the status of the ozone sensor 2 warm-up timer. After the required 15 -minute warm-up period, the processor initializes the ozone sensor 2, and checks the ozone sensor status to ensure there are no faults. If an error occurs, a window indicates the fault to the user, and the system returns to the Idle State. If no errors occur, the sterilization cycle begins.
- the ozone generator 1 and pump 6 turn on, the vent closes, and the ozone destruction unit 7 is bypassed.
- the processor monitors ozone concentration, and, the sterilization timer begins once the concentration reaches the user defined threshold. If ozone concentration falls below threshold at any time during sterilization, the sterilization timer pauses. If the "Stop"' button is pressed while the system is in the Sterilization State, the processor will advance to the Destruction State.
- the processor automatically enters the Destruction State.
- the ozone generator 1 is turned off, and solenoid valves 8 direct air through the ozone destruction unit 7.
- the destruction timer begins, The system continues to operate in the Destruction State until the destruction time reaches the defined destruction runtime. If the ⁇ -Stop" button is pressed while the device is in the Destruction State, the processor will return to the Idle State; however, there may still be ozone circulating in the system, so stopping the device using this method is not recommended. Otherwise, the processor indicates to the user when the sterilization is complete, and the system returns to the Idle State.
- the ozone sterilizer can be operated using battery power or standard 120 VAC power, A mechanical switch selects the type of power used during operation.
- the battery' pack used for the system may features a high discharge current and a long lifeeycle, such as a 12 VDC, rechargeable, lithium iron phosphate batter. This battery pack provides approximately 6 hours of continuous runtime, and an indicator on the user interface displays the status of the battery.
- a rectifier converts the 120 VAC into 12 VDC.
- the 12 VDC power is regulated to the voltage required by individual system components.
- all system components are controlled by TTL level digital signals generated by the chicken microprocessor.
- the TTL level signals drive a bank of opto-isolated solid-state relays, which apply or remove power to the ozone generator 1, pump 6, and air distribution valves 8 depending on the state of the controller (FIG 22).
- MRSA MethiciUm-resistant Staphylococcus aureus
- Klebsiella pneumoniae Klebsiella pneumoniae
- Escherichia coli Escherichia coli
- Bacillus subiilis Bacillus subiilis and Acinetobacter baumannii
- Bacteria included strains of Acinetobacter baumannii Klebsiella pneumonia, Escherichia call Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis (Table 1). Bacterial stock cultures were generated by growing cultures on 100mm plates containing nutrient agar at 37°C overnight. A single bacterial colony was picked using a sterile toothpick and added to 3 ml of sterile tryptiease soy broth or nutrient broth for A.
- the ozone generator (Model MP 8000 from A2Z Ozone Inc., Hudson, ⁇ H ) was connected to an ozone monitor (Model 454, Teledyne insrnmientations, San Diego, CA) via tygors tubing (outer diameter 6mrn, inner diameter 4mm), and subsequently to the sample case (Pelican 1500, Pelican Products, Torrance, CA) with dimensions 19" x 14,5" x 6,5" (1 x w x h) (depicted in FIG 1) (Dory, 2014). A small hole was drilled in the back of the briefcase with an inner diameter of 7mm through which the tubing was run through. The ozone chamber was placed in a certified chemical safety fume hood for ail studies.
- the ozone concentration was determined by UV using the Teiedyne model 454 ozone monitor (Teledyne Insuximentations, San Diego. CA), which can detect ozone from 0-50g/Nm with an accuracy of ⁇ 1%. Ozone concentrations were continuously monitored at each ozone output % for the entire
- experimental test period ranging from 5 minutes to 1 hour.
- Bacterial counting for each strain was perfomied by generating 10-fold serial from 10 -1 to 10 -8 . Bacteria were spread onto nutrient agar plates in duplicate by adding 100 ⁇ l of each dilution to each plate and grown overnight at 37°C without shaking. Dilution plates showing between 30-300 colonies were counted and the colony count was averaged from the duplicate plates and expressed in colony-forming units/nil (CFU/ml).
- the prototype ozone generator utilized for sterilization was rated at a maximum ozone output of 8 g/'Nm 3 when utilizing a pure gaseous oxygen source. However, given the desire for utilization of ambient air as the source for ozone generation, it was imperative to determine the ozone output under ambient air conditions.
- the ozone output was measured under four manufacturer settings, 25%, 50%, 75%, or 100%, at time periods ranging from 5 minutes to 60 minutes.
- the ozone output utilizing ambient air ranged from an average ozone concentration of 1.6 g/Nm 3 at 25% output to as high as 4.7 g/Nm 3 at 100% output, far below the manufacturer's reporting of 8 g/Nm" at 100% utilizing pure gaseous oxygen (Table 2).
- Bacterial strains from freezer stocks were diluted 1 : 100 in suitable sterile growth media in 50 ml propylene conical tubes, and grown overnight at 37 °C with shaking at 200 rpm. The following day, the cultures were diluted 1 : 10 in the appropriate media and aliquoted into the wells of a polystyrene, 12-well flat bottom plate (Costar #3512), The OD600 (Optical Density 600 run) was read using a BIOTEK ® SYNERGYTM HT spectrometer (BIGTEK ® Seattle, WA) with Gen5TM software version 2.01. Bacterial cultures were standardized to 1.5 QD/ml after the OD600 was determined.
- Serial dilutions were performed to quantify inoculum populations by generating 10-fold serial dilutions from 10-1 to 10-8. For specific quantification, 100 ⁇ l per dilution was spread onto nutrient agar plates and placed in a 37 °C incubator overnight.
- Turbidity and Spread Plate Assays Following ozone exposure, 2 ml of sterile media was added to each well in the test plate and the control plate to re-suspend the bacteria. After the bacteria were re-suspended, 200 ⁇ from each of the 10 treated wells and 3 control wells were plated without dilution on nutrient agar and placed in a 37 °C incubator overnight. Colony forming units (CPU's) were counted the following day.
- CPU's Colony forming units
- the 12-well plates with the remaining media were placed in the incubator at 37 °C overnight without shaking, The following day, the plates were removed and sealed with PCR sealing film (VWR catalog #82018-846) and the OD600 was read using a spectrometer, Turbidity was normalized by dividing the average turbidity of the ozone exposure wells by the average turbidity of the control wells. Each of the 10 treated wells and 10 control wells were measured independently.
- dental instruments including explorers, probes, hatchet, excavators, cotton pliers, spatulas, and mirrors, were treated in the closed-loop sterilizer configuration. Instruments were placed in 50 ml propylene conical tubes containing bacterial suspensions, with bacterial concentrations averaging 108 CFU/ml. The instruments were allowed to dry lying flat inside the laminar flow safety cabinet. A set of instruments was placed in the ozone sterilization chamber on top of a flat piece of aluminum foil and exposed to ozone for 60 minutes, and the control instruments were left in the laminar flow safety cabinet for the duration of the ozone exposure. Following exposure, tools were wrapped in the foil to prevent contamination and placed in the laminar flow hood. Each bacteria strain was treated in duplicate,
- Turbidity and Spread Plate Assays Bacterial growth in the 12-well plates was measured using the same methods described for the open-loop testing. For measuring bacterial growth on the dental instruments, the tools were placed in 50 ml propylene conical tubes containing 10 ml of sterile strain growth media for at least 15 minutes with occasional agitation. For spread plate assays, 100 ⁇ l of the media was plated on a 35 mm sterile nutrient agar plate. Ten-fold serial dilutions from 10 -1 to 10-5 were generated and 100 ⁇ ! per dilution were plated for control instruments. The agar plates were incubated overnight at 37 °C > and CFU's were counted the following day.
- Remaining media from control and test instruments was kept in the conical tubes for turbidity testing, and incubated overnight at 37 °C without shaking. The following day, 1 ml from each tube was ali quoted into one well in a 12-well flat bottom plate, the OD600 was read using the spectrometer, and the data were normalized using the method described above, RESULTS
- Ozone gas is an effective and practical antibacterial agent, American Journal of Infection Control, 36(8), 559-563.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
L'invention concerne ensemble autonome, réutilisable, facile à porter, léger et portable de stérilisation d'équipement contaminé à l'aide d'ozone et d'humidité générée in situ sans nécessiter d'électricité externe, des carburants ou d'autres sources d'énergie exogènes pour le fonctionnement. L'invention concerne également son procédé d'utilisation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462038171P | 2014-08-15 | 2014-08-15 | |
US62/038,171 | 2014-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016025934A1 true WO2016025934A1 (fr) | 2016-02-18 |
Family
ID=55304700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/045434 WO2016025934A1 (fr) | 2014-08-15 | 2015-08-15 | Stérilisateur à l'ozone portable autonome pour petit équipement médical |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016025934A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9849204B2 (en) | 2016-01-13 | 2017-12-26 | Sterio3, Llc | Sterilization device and methods |
US10039850B2 (en) | 2016-01-13 | 2018-08-07 | Sterio3, Llc | Sterilization device and methods |
WO2019012479A1 (fr) * | 2017-07-13 | 2019-01-17 | Sterio3, Llc | Dispositif et procédés de stérilisation |
CN109839963A (zh) * | 2019-01-23 | 2019-06-04 | 北京雪迪龙科技股份有限公司 | 一种紫外照射式臭氧发生器浓度控制方法 |
RU209283U1 (ru) * | 2021-08-26 | 2022-03-14 | Максим Александрович Мизгулин | Мобильная станция вакуумно-озоновой дезинфекции |
WO2024209238A1 (fr) * | 2023-04-05 | 2024-10-10 | Bioaera Austral Spa | Système et procédé de désinfection d'objets à l'aide d'ozone |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221520A (en) * | 1991-09-27 | 1993-06-22 | North Carolina Center For Scientific Research, Inc. | Apparatus for treating indoor air |
WO2001078793A1 (fr) * | 2000-04-12 | 2001-10-25 | Purizer Corporation | Procede de sterilisation pour steriliser l'air, un liquide ou des surfaces |
US7976791B2 (en) * | 2004-11-10 | 2011-07-12 | The United States Of America As Represented By The Secretary Of The Army | Portable chemical sterilizer |
US8354057B2 (en) * | 2006-11-29 | 2013-01-15 | Doug Heselton | Apparatus and method for using ozone as a disinfectant |
US20130243649A1 (en) * | 2009-09-30 | 2013-09-19 | Tso3 Inc. | Hydrogen peroxide sterilization method |
US20140105783A1 (en) * | 2012-10-17 | 2014-04-17 | Hantover, Inc. | Deodorizing and sanitizing container |
-
2015
- 2015-08-15 WO PCT/US2015/045434 patent/WO2016025934A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221520A (en) * | 1991-09-27 | 1993-06-22 | North Carolina Center For Scientific Research, Inc. | Apparatus for treating indoor air |
WO2001078793A1 (fr) * | 2000-04-12 | 2001-10-25 | Purizer Corporation | Procede de sterilisation pour steriliser l'air, un liquide ou des surfaces |
US7976791B2 (en) * | 2004-11-10 | 2011-07-12 | The United States Of America As Represented By The Secretary Of The Army | Portable chemical sterilizer |
US8354057B2 (en) * | 2006-11-29 | 2013-01-15 | Doug Heselton | Apparatus and method for using ozone as a disinfectant |
US20130243649A1 (en) * | 2009-09-30 | 2013-09-19 | Tso3 Inc. | Hydrogen peroxide sterilization method |
US20140105783A1 (en) * | 2012-10-17 | 2014-04-17 | Hantover, Inc. | Deodorizing and sanitizing container |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9849204B2 (en) | 2016-01-13 | 2017-12-26 | Sterio3, Llc | Sterilization device and methods |
US10039850B2 (en) | 2016-01-13 | 2018-08-07 | Sterio3, Llc | Sterilization device and methods |
WO2019012479A1 (fr) * | 2017-07-13 | 2019-01-17 | Sterio3, Llc | Dispositif et procédés de stérilisation |
CN109839963A (zh) * | 2019-01-23 | 2019-06-04 | 北京雪迪龙科技股份有限公司 | 一种紫外照射式臭氧发生器浓度控制方法 |
RU209283U1 (ru) * | 2021-08-26 | 2022-03-14 | Максим Александрович Мизгулин | Мобильная станция вакуумно-озоновой дезинфекции |
WO2024209238A1 (fr) * | 2023-04-05 | 2024-10-10 | Bioaera Austral Spa | Système et procédé de désinfection d'objets à l'aide d'ozone |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016025934A1 (fr) | Stérilisateur à l'ozone portable autonome pour petit équipement médical | |
JP5889836B2 (ja) | 殺菌システムおよび装置 | |
Bai et al. | Inactivation kinetics of Bacillus cereus spores by plasma activated water (PAW) | |
Boxhammer et al. | Bactericidal action of cold atmospheric plasma in solution | |
US7988930B2 (en) | Portable chemical sterilizer | |
US20240033386A1 (en) | A disinfection system, method and chamber thereof | |
Choudhury et al. | Inactivation of Pseudomonas aeruginosa and Methicillin-resistant Staphylococcus aureus in an open water system with ozone generated by a compact, atmospheric DBD plasma reactor | |
McCombs et al. | New discoveries and directions for medical, dental and dental hygiene research: low temperature atmospheric pressure plasma | |
WO2003077956A2 (fr) | Decontamination parametrique d'installations biocontaminees a l'aide de bioxyde de chlore gazeux | |
CN113144251B (zh) | 适用于密闭空间消杀新型冠状病毒的臭氧消毒设备 | |
Gierke et al. | Investigation on potential ESKAPE surrogates for 222 and 254 nm irradiation experiments | |
JP2017136191A (ja) | オゾンガス消毒器 | |
Abuzairi et al. | Development of the Sterilization Box for Medical Equipment with an Ozone Gas Leak Sensor Feature | |
Khurana | Ozone treatment for prevention of microbial growth in air conditioning systems | |
Lee | Surface and air: what impact does UV-C at the room level have on airborne and surface bacteria? | |
Kamlaskar et al. | Automatic room sanitization using UV-C tubes | |
Doona et al. | The Portable Chemical Sterilizer (PCS), D-FENS, and D-FEND ALL: novel chlorine dioxide decontamination technologies for the military | |
Duckworth | Ultraviolet light emitting diode use in advanced oxidation processes | |
Shartooh et al. | Increasing Sterilization Efficiency of Shredder Autoclave on Medical Waste Using Ultraviolet Light Device | |
US20240226355A9 (en) | Active plasma sterilizer with smart control | |
CN201414948Y (zh) | 空气净化消毒器 | |
BR202022016646U2 (pt) | Equipamento para esterilização de instrumentos médicos de estabelecimentos de saúde | |
CN205124952U (zh) | 一种臭氧消毒机 | |
Bandewar et al. | Plasma Technology in Disinfection and Sterilization: Core Principles and Emerging Innovations for Biological Applications | |
CN204072857U (zh) | 便携式可遥控的气体二氧化氯空间消毒装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15832502 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15832502 Country of ref document: EP Kind code of ref document: A1 |